American Journal of Medicine最新文献_第3页

Macaroni Sign: Point-of-care Ultrasound Identification of Takayasu Arteritis. 通心粉征：高须动脉炎的即时超声诊断。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-10 DOI: 10.1016/j.amjmed.2025.06.008

Eric Zhang, Jennifer Smiechowski, Emma E M Spence, Stefana Pancic, Irene W Y Ma

引用次数: 0

Hepatitis C Virus Associated Cryoglobulinemic Vasculitis. 丙型肝炎病毒相关的冷球蛋白性血管炎。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-10 DOI: 10.1016/j.amjmed.2025.05.051

Benjamin Y Hsieh, Mohamed Ismail, Menna-Allah Elaskandrany

引用次数: 0

A Decade of Hypnotherapy Research for Multiple Sclerosis Symptom Management: A Systematic Review. 催眠疗法对多发性硬化症症状管理的十年研究：系统回顾。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-10 DOI: 10.1016/j.amjmed.2025.05.049

Ahmet Onat Özdemir, Mauro Cozzolino, Osman Gurdal, Ivonne Carosi Arcangeli, Stefania Mancone, Giovanna Celia

{"title":"A Decade of Hypnotherapy Research for Multiple Sclerosis Symptom Management: A Systematic Review.","authors":"Ahmet Onat Özdemir, Mauro Cozzolino, Osman Gurdal, Ivonne Carosi Arcangeli, Stefania Mancone, Giovanna Celia","doi":"10.1016/j.amjmed.2025.05.049","DOIUrl":"https://doi.org/10.1016/j.amjmed.2025.05.049","url":null,"abstract":"This systematic review investigates the effectiveness of hypnotherapy for symptom control in multiple sclerosis (MS) patients. Following PRISMA guidelines, eight research (N=423 participants, sample sizes 15-173) were assessed using the PEDro scale. Hypnotherapy showed significant benefits, including a 30-45% reduction in pain intensity (p<0.01), an 8.19 point decrease in Multidimensional Fatigue Inventory scores (p<0.05), a 1.98-point improvement in Pittsburgh Sleep Quality Index scores (p<0.05), and a 3.7-point reduction in DASS-21 depression subscale. Optimal protocols included 8-10 weekly 45-60-minute sessions, with coupled treatments (hypnotherapy with neurofeedback or mindfulness) producing better results (additional 15-20% improvement). Follow-ups revealed that psychological advantages persisted, although pain alleviation decreased after 6 months without maintenance. The evidence suggests that hypnotherapy can be an effective additional strategy for MS symptom management, with hypnotic cognitive treatment exhibiting notable efficacy for tiredness and psychosocial problems. Methodological limitations demand larger trials with standardized methodologies.","PeriodicalId":50807,"journal":{"name":"American Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144286956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

An Integrative Approach to HPA Axis Dysfunction: From Recognition to Recovery. 下丘脑轴功能障碍的综合治疗：从认识到恢复。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-09 DOI: 10.1016/j.amjmed.2025.05.044

Melinda Ring

引用次数: 0

Elevated Lipoprotein(a): A Treatment Challenge and a Practical Solution. 脂蛋白升高(a)：一个治疗挑战和一个实用的解决方案。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-06 DOI: 10.1016/j.amjmed.2025.05.035

David S Schade, Allen Adolphe, Samuel Wann, R Philip Eaton

引用次数: 0

Impact of dual antiplatelet therapy duration on long-term outcomes following chronic total occlusion percutaneous coronary intervention. 双重抗血小板治疗持续时间对慢性全闭塞经皮冠状动脉介入治疗后长期预后的影响。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-06 DOI: 10.1016/j.amjmed.2025.05.038

Yao Jiang, Han Zhang, Chujie Zhang, Yingyang Geng, Yin Zhang, Changdong Guan, Kefei Dou, Yuejin Yang, Shubin Qiao, Yongjian Wu, Lei Song

{"title":"Impact of dual antiplatelet therapy duration on long-term outcomes following chronic total occlusion percutaneous coronary intervention.","authors":"Yao Jiang, Han Zhang, Chujie Zhang, Yingyang Geng, Yin Zhang, Changdong Guan, Kefei Dou, Yuejin Yang, Shubin Qiao, Yongjian Wu, Lei Song","doi":"10.1016/j.amjmed.2025.05.038","DOIUrl":"https://doi.org/10.1016/j.amjmed.2025.05.038","url":null,"abstract":"Background: Optimal dual antiplatelet therapy (DAPT) duration after percutaneous coronary intervention for coronary chronic total occlusion remains unclear. Thus, we aim to determine the optimal DAPT duration in this high-risk cohort with complex anatomy and procedures.Methods: Between January 2010 and December 2013, 2659 consecutive chronic total occlusion patients undergoing percutaneous coronary intervention at Fu Wai Hospital were enrolled, and those without adverse events within 12 months were categorized into long (>12 months) or short-term (≤12 months) groups according to DAPT duration. The primary endpoint was a composite of cardiac death and spontaneous myocardial infarction at 5 years. The safety endpoint was the rate of Bleeding Academic Research Consortium (BARC) 2, 3 or 5 type bleeding at 5 years.Results: Overall, 1923 patients were included in the final analysis, of which 1104 (57.4%) continued DAPT beyond 12 months. Compared with short-term DAPT, long-term DAPT was associated with a lower rate of primary outcome (3.6% vs. 6.3%; adjusted hazard ratio[aHR]: 0.58 [95% CI, 0.38 to 0.89], p=0.01), primarily driven by fewer cardiac death (0.1% vs. 4.0%, aHR:0.02 [95% CI, 0.00 to 0.17]; p<0.001); and a higher risk of BARC 2-5 bleeding (3.8% vs. 1.5%; aHR: 2.61 [95% CI, 1.37 to 4.97], p<0.01), whereas the risk of BARC 3 or greater was comparable between groups.Conclusion: In patients undergoing chronic total occlusion percutaneous coronary intervention, prolonged DAPT was associated with a reduced risk of cardiac death and myocardial infarction, but with an increased risk of minor bleeding.","PeriodicalId":50807,"journal":{"name":"American Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trust and Value in AI-Driven Medicine. 人工智能医学中的信任与价值。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-05 DOI: 10.1016/j.amjmed.2025.06.001

Ruchi Bhatia

引用次数: 0

A Call for Healthcare Providers to Address Faith, Religiosity, and Spirituality among Older Adults. 呼吁医疗保健提供者解决老年人的信仰、宗教信仰和灵性问题。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-04 DOI: 10.1016/j.amjmed.2025.05.048

Hawa O Abu

引用次数: 0

Physician Mental Health: Understanding Physician Burnoutand Solutions for Well-Being. 医生心理健康：了解医生的倦怠和健康的解决方案。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-04 DOI: 10.1016/j.amjmed.2025.05.039

Diana Hsiao, Adithi A Tirumalai, Justina John, Sohum Sheth, Beth Frates, Dean Ornish, Monica Aggarwal

引用次数: 0

The performance of biomarkers for the diagnosis of Parkinson's disease: A systematic review. 生物标志物在帕金森病诊断中的作用：系统综述。

IF 2.5 3区医学

American Journal of Medicine Pub Date : 2025-06-03 DOI: 10.1016/j.amjmed.2025.05.047

Jaden Lim, Yeonglong Ay

{"title":"The performance of biomarkers for the diagnosis of Parkinson's disease: A systematic review.","authors":"Jaden Lim, Yeonglong Ay","doi":"10.1016/j.amjmed.2025.05.047","DOIUrl":"https://doi.org/10.1016/j.amjmed.2025.05.047","url":null,"abstract":"Background: Early diagnosis of Parkinson's disease remains challenging due to the current clinical diagnostic approach. With machine learning emerging as a powerful tool for biomarker discovery, we aim to determine whether biomarkers processed by machine learning models can enable earlier detection of Parkinson's disease.Methods: We conducted a literature search with a 10-year limit that yielded 161 biomarkers derived from serum, cerebrospinal fluid and genes. Initially, biomarkers were classified into four groups according to the biological timeline of Parkinson's disease pathogenesis. Subsequently, we further organised the biomarkers into two categories: pre-motor phase and motor phase biomarkers. Two analyses were then conducted according to the aforementioned classifications, with the performance of biomarkers evaluated via their AUC values as derived from machine learning models.Results: No significant differences were found in either analysis, suggesting that all biomarkers, regardless of their role in the biological sequences underpinning Parkinson's disease pathogenesis, nor their association with the pre-motor or motor phases of Parkinson's disease, have the potential to serve as equally valid diagnostic predictors. Additionally, we identified 26 top-performing biomarkers with high AUC values (>0.8).Conclusion: The main finding in our analyses was that pre-motor phase biomarkers, which offer the advantage of enabling an earlier diagnosis compared to clinical methods, can achieve a comparably high level of diagnostic accuracy as motor phase biomarkers. Therefore, our foremost suggestion is further research into the clinical viability of pre-motor phase biomarkers that compose part of the aforementioned 26 top-performing biomarkers.","PeriodicalId":50807,"journal":{"name":"American Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144235848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0